ToxGlobal Diagnostics Philadelphia, PA - 19131

ToxGlobal Diagnostics is categorized under Drug Detection Service and Equipment in Philadelphia, PA and active since 2013.

ToxGlobal Diagnostics was established in 2013, and today employs 1 to 4, earning Unknown per year. This is a Drug Detection Service and Equipment business, which does work in the B2C market, and is classified as a Drug Detection Service and Equipment, under code number by the NAICS.

If you are seeking more information, feel free to contact Augustine Agyekum at the company’s headquarters by writing to 5070 Parkside Ave
Suite 2103, Philadelphia, Pennsylvania PA 19131 or by phoning (877) 225-0316. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: ToxGlobal Diagnostics
Contact Person: Augustine Agyekum
Address: 5070 Parkside Ave
Suite 2103, Philadelphia, Pennsylvania 19131
Phone Number: (877) 225-0316
Website Address: toxglobal.com/
Annual Revenue (USD): Unknown
Founded: 2013
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drug Detection Service and Equipment
Share This Business:

ToxGlobal Diagnostics was started in 2013 to provide professional Drug Detection Service and Equipment under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Augustine Agyekum for inquiries that concern ToxGlobal Diagnostics by calling the company number (877) 225-0316, as your correspondence is most welcome. Additionally, the physical location of the headquarters of ToxGlobal Diagnostics can be found at the coordinates 39.9800327,-75.22110950 as well as the street address 5070 Parkside Ave
Suite 2103
in Philadelphia, Pennsylvania 19131.

For its online presence, you may visit ToxGlobal Diagnostics’s website at toxglobal.com/ and engage with its social media outlets through on Twitter and on Facebook.